Atlas Trials

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Clinical trial NCT00608361 · COMPLETED

Trial details

NCT number
NCT00608361
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular CarcinomaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid NeoplasmAdult T Acute Lymphoblastic LeukemiaAdvanced Adult Hepatocellular CarcinomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell LymphomaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
Start date
2008-10-01
Primary completion
2014-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.